Location History:
- Allschwil, CH (1983 - 2014)
- Austria, CH (2015)
Company Filing History:
Years Active: 1983-2015
Title: The Innovative Contributions of Peter C. Hiestand
Introduction
Peter C. Hiestand, an accomplished inventor based in Allschwil, Switzerland, has made significant contributions to the field of pharmaceutical innovations. With a remarkable portfolio of seven patents, Hiestand's work primarily focuses on the development of S1P receptor modulators for the treatment of multiple sclerosis and related demyelinating diseases.
Latest Patents
Among his latest inventions, one notable patent is centered around S1P receptor modulators designed for treating relapsing-remitting multiple sclerosis. This invention relates to the potential uses of an S1P receptor modulator such as 2-substituted 2-amino-propane-1,3-diol or 2-amino-propanol derivatives. Specifically, it highlights a compound comprising a group of formula X aimed at preventing neo-angiogenesis associated with demyelinating diseases.
Another patent focuses on the S1P receptor modulator 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol, which is administered at a daily dosage of 0.5 mg. This invention aims to inhibit or treat neo-angiogenesis related to multiple sclerosis, showcasing Hiestand's commitment to addressing critical health challenges.
Career Highlights
Throughout his career, Peter C. Hiestand has worked with prominent companies such as Novartis AG and Sandoz GmbH. His experience at these leading pharmaceutical organizations has undoubtedly contributed to the depth of his knowledge and the quality of his inventions.
Collaborations
In his journey as an inventor, Hiestand has collaborated with talented professionals, including Murat Acemoglu and Siegfried Bantle. These collaborations have enhanced his research and innovation processes, leading to groundbreaking developments in pharmaceutical solutions.
Conclusion
Peter C. Hiestand's impactful work and innovative patents represent significant advancements in the treatment of multiple sclerosis. His dedication to addressing complex health issues and collaborating with other experts marks him as a notable figure in the field of medical inventions. As research continues, Hiestand's contributions are likely to influence future treatments and improve patient outcomes.